Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice

Multiple sclerosis (MS) is an autoimmune chronic disease of the central nervous system (CNS) characterized by immune-mediated inflammation, demyelination and subsequent axonal damage. Gene expression profiling showed that Nurr1, an orphan nuclear receptor, is down-regulated in peripheral blood monon...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 9; no. 9; p. e108791
Main Authors: Montarolo, Francesca, Raffaele, Chiara, Perga, Simona, Martire, Serena, Finardi, Annamaria, Furlan, Roberto, Hintermann, Samuel, Bertolotto, Antonio
Format: Journal Article
Language:English
Published: United States Public Library of Science 29-09-2014
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multiple sclerosis (MS) is an autoimmune chronic disease of the central nervous system (CNS) characterized by immune-mediated inflammation, demyelination and subsequent axonal damage. Gene expression profiling showed that Nurr1, an orphan nuclear receptor, is down-regulated in peripheral blood mononuclear cells of MS patients. Nurr1 exerts an anti-inflammatory role repressing the activity of the pro-inflammatory transcription factor NF-kB. Here, we report that the preventive treatment with isoxazolo-pyridinone 7e, an activator of Nurr1 signaling pathway, reduces the incidence and the severity of a MS murine model, i.e. experimental autoimmune encephalomyelitis (EAE). The compound is able to attenuate inflammation and neurodegeneration in spinal cords of EAE mice by an NF-kB pathway-dependent process.
Bibliography:Competing Interests: Author S.H. is paid employee, owns shares and is a co-author on a patent application belonging to Novartis S.p.a. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: FM CR SP SM AF RF SH AB. Performed the experiments: FM CR AF. Analyzed the data: FM CR SP SM AF RF AB. Contributed reagents/materials/analysis tools: RF AB. Wrote the paper: FM SP SM AF RF SH AB.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0108791